Fibromyalgia: A primer for the anesthesia community

Current Opinion in Anaesthesiology

Volumn 24, Issue 5, 2011, Pages 532-539

  Brummett, Chad M ^a   Clauw, Daniel J ^a  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

anesthesiology; chronic postsurgical pain; fibromyalgia; postoperative pain; treatment

Indexed keywords

4 AMINOBUTYRIC ACID; AMITRIPTYLINE; CITALOPRAM; DULOXETINE; ESCITALOPRAM; GABAPENTIN; GLUTAMIC ACID; MILNACIPRAN; MU OPIATE RECEPTOR; NONSTEROID ANTIINFLAMMATORY AGENT; NORADRENALIN; OPIATE; OXYBATE SODIUM; PREGABALIN; REBOXETINE; SEROTONIN; SUBSTANCE P;

ABDOMINAL CRAMP; ABDOMINAL PAIN; ANALGESIA; ANESTHESIST; ANXIETY DISORDER; CEREBROSPINAL FLUID LEVEL; CHRONIC FATIGUE SYNDROME; CHRONIC PAIN; CHRONIC PROSTATITIS; COGNITIVE DEFECT; COGNITIVE THERAPY; DEPRESSION; DRUG EFFICACY; DRUG SAFETY; DRY EYE; ESOPHAGUS DISEASE; FATIGUE; FIBROMYALGIA; GASTROINTESTINAL DISEASE; GENETIC PREDISPOSITION; HEADACHE; HEARING; HUMAN; INTERSTITIAL CYSTITIS; LOW BACK PAIN; MEMORY DISORDER; NEUROTRANSMISSION; NOCICEPTION; NONCARDIAC CHEST PAIN; PAIN ASSESSMENT; PATHOPHYSIOLOGY; PERCEPTION DISORDER; PERCEPTIVE THRESHOLD; PHYSICAL EXAMINATION; POSTOPERATIVE PAIN; PRIORITY JOURNAL; PROPRIOCEPTION; RANDOMIZED CONTROLLED TRIAL (TOPIC); RECEPTOR OCCUPANCY; REVIEW; SEX DIFFERENCE; SLEEP DISORDER; SPECTROSCOPY; TEMPOROMANDIBULAR JOINT DISORDER; UNSPECIFIED SIDE EFFECT; VULVODYNIA;

ACUTE DISEASE; ANESTHESIOLOGY; COMORBIDITY; FIBROMYALGIA; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MENTAL DISORDERS; PAIN MANAGEMENT; PAIN MEASUREMENT; PAIN PERCEPTION; PAIN, POSTOPERATIVE; SENSATION; SYNAPTIC TRANSMISSION;

EID: 80052676816     PISSN: 09527907     EISSN: 14736500     Source Type: Journal    
DOI: 10.1097/ACO.0b013e32834a1091     Document Type: Review

References (59)

1. Ablin K, Clauw DJ. From fibrositis to functional somatic syndromes to a bell-shaped curve of pain and sensory sensitivity: evolution of a clinical construct. Rheum Dis Clin North Am 2009; 35:233-251.
2. Aaron LA, Burke MM, Buchwald D. Overlapping conditions among patients with chronic fatigue syndrome, fibromyalgia, and temporomandibular disorder. Arch Intern Med 2000; 160:221-227. (Pubitemid 30054342)
3. Giesecke T, Gracely RH, Grant MA, et al. Evidence of augmented central pain processing in idiopathic chronic low back pain. Arthritis Rheum 2004; 50:613-623. (Pubitemid 38198845)
4. Gwilym SE, Keltner JR, Warnaby CE, et al. Psychophysical and functional imaging evidence supporting the presence of central sensitization in a cohort of osteoarthritis patients. Arthritis Rheum 2009; 61:1226-1234.
5. Lee YC, Chibnik LB, Lu B, et al. The relationship between disease activity, sleep, psychiatric distress and pain sensitivity in rheumatoid arthritis: a cross-sectional study. Arthritis Res Ther 2009; 11:R160.
6. Lee YC, Nassikas NJ, Clauw DJ. The role of the central nervous system in the generation and maintenance of chronic pain in rheumatoid arthritis, osteoarthritis and fibromyalgia. Arthritis Res Ther 2011; 13:211.
7. Wolfe F. Fibromyalgianess. Arthritis Rheum 2009; 61:715-716.
8. Wolfe F, Michaud K. Outcome and predictor relationships in fibromyalgia and rheumatoid arthritis: evidence concerning the continuum versus discrete disorder hypothesis. J Rheumatol 2009; 36:831-836.
9. Arnold LM, Clauw DJ. Fibromyalgia syndrome: practical strategies for improving diagnosis and patient outcomes. Am J Med 2010; 123:S2.
10. Wolfe F, Smythe HA, Yunus MB, et al. The American College of Rheumatology 1990 criteria for the classification of fibromyalgia. Report of the multi-center criteria committee. Arthritis Rheum 1990; 33:160-172. (Pubitemid 20098653)
11. Wolfe F, Clauw DJ, Fitzcharles MA, et al. The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity. Arthritis Care Res (Hoboken) 2010; 62:600-610.
12. McBeth J, Jones K. Epidemiology of chronic musculoskeletal pain. Best Pract Res Clin Rheumatol 2007; 21:403-425. (Pubitemid 46972006)
13. Wolfe F, Ross K, Anderson J, et al. Aspects of fibromyalgia in the general population: sex, pain threshold, and fibromyalgia symptoms. J Rheumatol 1995; 22:151-156.
14. Diatchenko L, Nackley AG, Tchivileva IE, et al. Genetic architecture of human pain perception. Trends Genet 2007; 23:605-613. (Pubitemid 350186068)
15. Arnold LM, Hudson JI, Hess EV, et al. Family study of fibromyalgia. Arthritis Rheum 2004; 50:944-952. (Pubitemid 38326195)
16. Geisser ME, Glass JM, Rajcevska LD, et al. A psychophysical study of auditory and pressure sensitivity in patients with fibromyalgia and healthy controls. J Pain 2008; 9:417-422.
17. Geisser ME, Strader Donnell C, Petzke F, et al. Comorbid somatic symptoms and functional status in patients with fibromyalgia and chronic fatigue syndrome: sensory amplification as a common mechanism. Psychosomatics 2008; 49:235-242. (Pubitemid 351681643)
18. Nebel MB, Gracely RH. Neuroimaging of fibromyalgia. Rheum Dis Clin North Am 2009; 35:313-327.
19. Yarnitsky D. Conditioned pain modulation (the diffuse noxious inhibitory control-like effect): its relevance for acute and chronic pain states. Curr Opin Anaesthesiol 2010; 23:611-615.
20. Giesecke T, Gracely RH, Williams DA, et al. The relationship between depression, clinical pain, and experimental pain in a chronic pain cohort. Arthritis Rheum 2005; 52:1577-1584. (Pubitemid 40663950)
21. Paul-Savoie E, Potvin S, Daigle K, et al. A deficit in peripheral serotonin levels in major depressive disorder but not in chronic widespread pain. Clin J Pain 2011; 27:529-534.
22. Dadabhoy D, Crofford LJ, Spaeth M, et al. Biology and therapy of fibromyalgia. Evidence-based biomarkers for fibromyalgia syndrome. Arthritis Res Ther 2008; 10:211.
23. Harris RE, Sundgren PC, Craig AD, et al. Elevated insular glutamate in fibromyalgia is associated with experimental pain. Arthritis Rheum 2009; 60:3146-3152.
24. Harris RE, Sundgren PC, Pang Y, et al. Dynamic levels of glutamate within the insula are associated with improvements in multiple pain domains in fibromyalgia. Arthritis Rheum 2008; 58:903-907. (Pubitemid 351364893)
25. Harris RE, Clauw DJ, Scott DJ, et al. Decreased central mu-opioid receptor availability in fibromyalgia. J Neurosci 2007; 27:10000-10006. (Pubitemid 47404015)
26. Xiao Y, He W, Russell IJ. Genetic Polymorphisms of the {beta}2-adrenergic receptor relate to guanosine protein-coupled stimulator receptor dysfunction in fibromyalgia syndrome. J Rheumatol 2011; 38:1095-1103.
27. Lee YH, Choi SJ, Ji JD, et al. Candidate gene studies of fibromyalgia: a systematic review and meta-analysis. Rheumatol Int2010. [Epub ahead of print]
28. Arnold LM, Clauw DJ, McCarberg BH. Improving the recognition and diagnosis of fibromyalgia. Mayo Clin Proc 2011; 86:457-464.
29. Hauser W, Bernardy K, Uceyler N, et al. Treatment of fibromyalgia syndrome with antidepressants: a meta-analysis. JAMA 2009; 301:198-209.
30. Hauser W, Petzke F, Sommer C. Comparative efficacy and harms of dulox-etine, milnacipran, and pregabalin in fibromyalgia syndrome. J Pain 2010; 11:505-521.
31. Clauw DJ. Pain management: Fibromyalgia drugs are 'as good as it gets' in chronic pain. Nat Rev Rheumatol 2010; 6:439-440.
32. Arnold LM, Keck PE Jr, Welge JA. Antidepressant treatment of fibromyalgia. A meta-analysis and review. Psychosomatics 2000; 41:104-113.
33. Hauser W, Bernardy K, Uceyler N, et al. Treatment of fibromyalgia syndrome with gabapentin and pregabalin-a meta-analysis of randomized controlled trials. Pain 2009; 145 (1-2):69-81.
34. Arnold LM, Goldenberg DL, Stanford SB, et al. Gabapentin in the treatment of fibromyalgia: a randomized, double-blind, placebo-controlled, multicentertrial. Arthritis Rheum 2007; 56:1336-1344.
35. Russell IJ, Holman AJ, Swick TJ, et al. Sodium oxybate reduces pain, fatigue, and sleep disturbance and improves functionality in fibromyalgia: results from a 14-week, randomized, double-blind, placebo-controlled study. Pain 2011; 152:1007-1017.
36. Lynch ME, Campbell F. Cannabinoids for treatment of chronic non-cancer pain; a systematic review of randomized trials. Br J Clin Pharmacol 2011. [Epub ahead of print]
37. Skrabek RQ, Galimova L, Ethans K, et al. Nabilone for the treatment of pain in fibromyalgia. J Pain 2008; 9:164-173.
38. Cohen SP, Verdolin MH, Chang AS, et al. The intravenous ketamine test predicts subsequent response to an oral dextromethorphan treatment regimen in fibromyalgia patients. J Pain 2006; 7:391-398. (Pubitemid 44208832)
39. Noppers I, Niesters M, Swartjes M, et al. Absence of long-term analgesic effect from a short-term S-ketamine infusion on fibromyalgia pain: a randomized, prospective, double blind, active placebo-controlled trial. Eur J Pain 2011. [Epub ahead of print]
40. Lefaucheur JP. Is rTMS a therapeutic option in chronic pain syndrome? Insights from the treatment of fibromyalgia. Pain 2011; 152:1447-1448.
41. Mhalla A, Baudic S, de Andrade DC, et al. Long-term maintenance of the analgesic effects of transcranial magnetic stimulation in fibromyalgia. Pain 2011.
42. Roizenblatt S, Fregni F, Gimenez R, et al. Site-specific effects of transcranial direct current stimulation on sleep and pain in fibromyalgia: a randomized, sham-controlled study. Pain Pract 2007; 7:297-306. (Pubitemid 350142298)
43. Valle A, Roizenblatt S, Botte S, et al. Efficacy of anodal transcranial direct current stimulation (tDCS) for the treatment of fibromyalgia: results of a randomized, sham-controlled longitudinal clinical trial. J Pain Manag 2009; 2:353-361.
44. Goldenberg DL. Multidisciplinary modalities in the treatment of fibromyalgia. J Clin Psychiatry 2008; 69 (Suppl 2):30-34.
45. Williams DA, Kuper D, Segar M, et al. Internet-enhanced management of fibromyalgia: a randomized controlled trial. Pain 2010; 151:694-702.
46. Fontaine KR, Conn L, Clauw DJ. Effects of lifestyle physical activity on perceived symptoms and physical function in adults with fibromyalgia: results of a randomized trial. Arthritis Res Ther 2010; 12:R55.
47. Fontaine KR, Conn L, Clauw DJ. Effects of lifestyle physical activity in adults with fibromyalgia: results at follow-up. J Clin Rheumatol 2011; 17:64-68.
48. Hsu MC, Schubiner H, Lumley MA, et al. Sustained pain reduction through affective self-awareness in fibromyalgia: a randomized controlled trial. J Gen Intern Med 2010; 25:1064-1070.
49. Buvanendran A, Kroin JS. Multimodal analgesia for controlling acute postoperative pain. Curr Opin Anaesthesiol 2009; 22:588-593.
50. Zhang J, Ho KY, Wang Y. Efficacy of pregabalin in acute postoperative pain: a meta-analysis. Br J Anaesth 2011; 106:454-462.
51. Dworkin RH, McDermott MP, Raja SN. Preventing chronic postsurgical pain: how much of a difference makes a difference? Anesthesiology 2010; 112:516-518.
52. Kehlet H, Rathmell JP. Persistent postsurgical pain: the path forward through better design of clinical studies. Anesthesiology 2010; 112:514-515.
53. Kehlet H, Jensen TS, Woolf CJ. Persistent postsurgical pain: risk factors and prevention. Lancet 2006; 367:1618-1625. (Pubitemid 43674227)
54. Kurtz S, Ong K, Lau E, et al. Projections of primary and revision hip and knee arthroplasty in the United States from 2005 to 2030. J Bone Joint Surg Am 2007; 89:780-785. (Pubitemid 46564282)
55. Wylde V, Hewlett S, Learmonth ID, et al. Persistent pain after joint replacement: prevalence, sensory qualities, and postoperative determinants. Pain 2011; 152:566-572.
56. Wylde V, Dieppe P, Hewlett S, et al. Total knee replacement: is it really an effective procedure for all? Knee 2007; 14:417-423. (Pubitemid 350137747)
57. Nikolajsen L, Kristensen AD, Thillemann TM, et al. Pain and somatosensory findings in patients 3 years after total hip arthroplasty. Eur J Pain 2008; 13:576-581.
58. Bourne RB, Chesworth BM, Davis AM, et al. Patient satisfaction after total knee arthroplasty: who is satisfied and who is not? Clin Orthop Relat Res 2010; 468:57-63.
59. Brummett CM, Hassett AL. Pain: More than just a number. Reg Anesth Pain Med 2011; 36:314-316.